Muhammad Zulfiqah Sadikan

Dr. Muhammad Zulfiqah Sadikan

Center for Neuroscience Research (NeuRon)
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
Muhammad Zulfiqah SadikanMuhammad Zulfiqah Sadikan
Muhammad Zulfiqah Sadikan
NNNurul Alimah Abdul Nasir
Nurul Alimah Abdul Nasir
RARenu Agarwal
Renu Agarwal
NINafeeza Mohd Ismail
Nafeeza Mohd Ismail
Oxidative stress plays an important role in retinal neurodegeneration and angiogenesis associated with diabetes. In this study, we investigated the effect of the tocotrienol-rich fraction (TRF), a potent antioxidant, against diabetes-induced changes in retinal layer thickness (RLT), retinal cell count (RCC), retinal cell apoptosis, and retinal expression of vascular endothelial growth factor (VEGF) in rats. Additionally, the efficacy of TRF after administration by two different routes was compared. The diabetes was induced in Sprague-Dawley rats by intraperitoneal injection of streptozotocin. Subsequently, diabetic rats received either oral or topical treatment with vehicle or TRF. Additionally, a group of non-diabetic rats was included with either oral or topical treatment with a vehicle. After 12 weeks of the treatment period, rats were euthanized, and retinas were collected for measurement of RLT, RCC, retinal cell apoptosis, and VEGF expression. RLT and RCC in the ganglion cell layer were reduced in all diabetic groups compared to control groups (p < 0.01). However, at the end of the experimental period, oral TRF-treated rats showed a significantly greater RLT compared to topical TRF-treated rats. A similar observation was made for retinal cell apoptosis and VEGF expression. In conclusion, oral TRF supplementation protects against retinal degenerative changes and an increase in VEGF expression in rats with streptozotocin-induced diabetic retinopathy. Similar effects were not observed after topical administration of TRF.

8 August 2024 in International Journal of Transformative Health Professions Education
Verified
Journal Article
Open access
PDF file
Muhammad Zulfiqah SadikanMuhammad Zulfiqah Sadikan
Muhammad Zulfiqah Sadikan
IAIndang Ariati Ariffin
Indang Ariati Ariffin
Interprofessional collaboration (IPC) in medical education is critical for equipping future healthcare providers to successfully address the complex problems of today’s healthcare system. Current review investigates the theoretical frameworks, advantages, barriers, innovations, assessment and future direction of IPC initiatives in medical education. Some of the theoretical frameworks, for example, the Interprofessional Education Collaborative (IPEC) Core Competencies and the Collaborative Care Model, serve as a foundation for understanding the principles and processes of IPC. IPC implies a boost in teamwork skills, development of communication skills, better understanding of roles and functions, enhancement of patient-centred care, and preparation for interdisciplinary practice. Nevertheless, some of the challenges, such as logistic constraints, faculty resistance, cultural barriers, lack of interdisciplinarity, and assessment problems hamper the implementation of some IPC initiatives. Future directions include Interprofessional Education (IPE) integration into curricula, health equity as a focus, technology-enhanced learning platforms embracement, interdisciplinary research, scholarship promotion, and fostering global collaboration and exchange. Through the establishment of such challenges and accepting future directions, medical schools will prepare learners to work well with teams and lead in healthcare. IPC in medical education is not just an educational strategy but a transforming force that has the potential to change healthcare systems, improve patient outcomes, and promote health equity as a whole.

1 January 2025 in Scientifica
Verified
Journal Article
Open access
Muhammad Zulfiqah SadikanMuhammad Zulfiqah Sadikan
Muhammad Zulfiqah Sadikan
LLLidawani Lambuk
Lidawani Lambuk
HHHaryati Ahmad Hairi
Haryati Ahmad Hairi
RMRohimah Mohamud
Rohimah Mohamud
Magnesium (Mg) is a crucial mineral that is required for maintaining many of the physiological processes, including immune regulation. The immune system is a protective strategy against pathogenic infection, allergic reaction and tumour development. Dysregulation of immune functions results in different pathological conditions, including autoimmune disease, allergic diseases and infectious diseases. Mg plays a role in the modulation of immune responses through the regulation of the activation, proliferation and differentiation of immune cells. Moreover, research has shown that Mg participates in the treatment and prevention of different diseases, so it may serve as a therapeutic drug. Mg immunoregulatory activity and its applications in prevention and treatment of immune‐related disorders are discussed herein. Immunosuppression, reduced phagocytosis and suppressed natural killer cell function were associated with low concentrations of Mg, and these are critical for protection against viruses. Mg further affects inflammatory cytokine release and modulation of NF‐κB, a key immune signalling cascade. Evidence corroborates that supplementation with Mg might alleviate symptoms of immune diseases like SLE, bronchial asthma, inflammatory bowel disease and microbial infection. However, it is critical to conduct trials for establishing optimum dosing paradigms as well as the long‐term impact of Mg supplementation in the frame of immune disease.

21 January 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
HHHaryati Ahmad Hairi
Haryati Ahmad Hairi
NMnor hidayah mustafa
nor hidayah mustafa
ASAhmad Nazrun Shuid
Ahmad Nazrun Shuid
Muhammad Zulfiqah SadikanMuhammad Zulfiqah Sadikan
Muhammad Zulfiqah Sadikan
Background/Objectives: Diabetic osteoporosis (DOP) is a metabolic bone disorder marked by reduced bone mass, impaired microarchitecture and elevated fracture risk arising from type 1 and type 2 diabetes. Understanding its pathophysiology is essential for developing effective interventions. Method: A broad literature search of Scopus and PubMed (2015–2025) using diabetic osteoporosis-related keywords identified relevant English in vivo studies, which were screened, extracted, and narratively summarised for this review. Results: In vivo models, including high-fat-diet (HFD), streptozotocin (STZ) and combined HFD + STZ protocols, are widely used to investigate DOP mechanisms. HFD models mimic obesity-induced insulin resistance, chronic hyperglycaemia and low-grade inflammation, leading to suppressed osteoblast activity, enhanced osteoclastogenesis and accumulation of advanced glycation end products (AGEs). Ultimately, they compromise bone microarchitecture and mechanical strength. STZ models replicate type 1 diabetes by inducing β-cell destruction, insulin deficiency, oxidative stress, osteoblast apoptosis and inflammatory pathways promoting bone resorption. The combined HFD + STZ model integrates insulin resistance and partial β-cell dysfunction, closely reflecting type 2 diabetes pathology, including trabecular bone loss, collagen glycation and disrupted osteoblast–osteoclast signalling. Mechanistically, DOP involves impaired insulin/IGF-I signalling, AGE–RAGE interactions, oxidative stress and inflammation, resulting in diminished bone formation and quality. These models provide robust platforms for exploring molecular mechanisms and evaluating potential therapies, including Wnt pathway modulators, antioxidants and ferroptosis inhibitors. Conclusions: Collectively, preclinical in vivo models are indispensable for understanding DOP pathophysiology and developing strategies to mitigate diabetic bone fragility.

1 January 2025 in Scientifica
Verified
Journal Article
Open access
MSMohmmad Ashaq Sofi
Mohmmad Ashaq Sofi
MSMohd Abass Sofi
Mohd Abass Sofi
ANIMA NandaANIMA Nanda
ANIMA Nanda
BNB. K. Nayak
B. K. Nayak
ZOZulhabri Othman
Zulhabri Othman
Muhammad Zulfiqah SadikanMuhammad Zulfiqah Sadikan
Muhammad Zulfiqah Sadikan
Medicinal plants have been used for centuries as therapeutic compounds to address various health issues. Their rich phytochemical composition offers diverse bioactive substances with potential health benefits. This study aimed to explore the therapeutic potential of Podophyllum hexandrum root extract by investigating its chemical composition and antimicrobial, antioxidant, and anticancer properties. The phytochemical profiling of P. hexandrum root was conducted using GC‐MS analysis, which identified 26 compounds in the extract. The ethanolic root extract displayed strong inhibitory effects in the well diffusion assay against all tested microbes, with minimum inhibitory concentration (MIC) values ranging from 64 to 256 μg/mL. Candida albicans exhibited the lowest MIC value of 64 μg/mL. The antioxidant activity of the extracts was compared to standard antioxidant, revealing a dose‐dependent response with a notable radical scavenging activity of 59.23% at 100 μg/mL. Furthermore, the extract demonstrated strong cytotoxic effects against the human cancer cell line HT‐29, with IC 50 values of 38.20 and 32.5 μg/mL for 24 and 48 h. Overall, this study emphasizes the remarkable antibacterial, antioxidant, and anticancer properties of P. hexandrum root extract.

21 July 2026 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
FMFaiz Mahmood
Faiz Mahmood
NNNoman Nazeer
Noman Nazeer
MRM. M. Rekha
M. M. Rekha
KAKhalaf F. Alsharif
Khalaf F. Alsharif
FAFuad M. Alzahrani
Fuad M. Alzahrani
Muhammad Zulfiqah SadikanMuhammad Zulfiqah Sadikan
Muhammad Zulfiqah Sadikan
The green synthesis method was developed to manufacture of iron oxide nanoparticles using Eucalyptus globulus leaf extract as a reducing and stabilizing agent. Identification of Prepared Nanoparticles the identity of synthesized nanoparticles was unequivocally determined as α-Fe 2 O 3 (hematite) from XRD analysis showing the rhombohedral crystal structure (JCPDS No: 33-0664); earlier drafts inconsistently referred to preparation as Fe3O4 and this has been changed throughout this manuscript for consistency. SEM, EDX, FTIR XRD and DLS were used to characterize the morphology, composition and structure of the nanoparticles. Particles on the other hand, had quasi-spherical morphology as well as relatively low average diameters (10.84 ± 5.22 nm) and high crystallinity. FTIR analysis validates the potential role of phytomolecules as capping and stabilizing agents. The photocatalytic experimental notation corrected: almost ~99% degradation of Rhodamine B dye under visible light irradiation (λ ≥ 420 nm) in 340 min pseudo-first-order kinetics ( k = 0.0079 min −1 ). Antioxidant activity of HDPC using DCFH-DA assay: DCFH-DA assay for the measurement of intracellular ROS was performed on the different concentrations (0, 0.1, 0.5, and 2 mg/ml) of EPE which confirmed a concentration-dependent reduction of intracellular ROS in HDPC with ~70% reduction in fluorescence at the highest delivery rate (0.5 mg/ml). The reduction in ROS observed was indicative of real antioxidant activity as cell viability (MTT assay) confirmed this effect to be non-cytotoxic. It exhibited pronounced antibacterial activity against Escherichia coli, Staphylococcus aureus and Bacillus subtilis (ATCC 6633), with S. aureus being the most sensitive strain. MIC values: S. aureus 0.25 mg/ml; E. coli 0.50 mg/ml; B. subtilis 0.50 mg/ml. The green Fe 2 O 3 nanoparticles exhibited multifunctional photocatalytic properties, as well as antioxidant and antibacterial activity, making them novel frontline agents for environmental remediation and biomedicine.